{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T16:15:07Z","timestamp":1769530507752,"version":"3.49.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioinform."],"abstract":"<jats:p>Pancreatic Ductal Adenocarcinoma (PDAC) poses a significant health threat characterized by poor clinical outcomes, largely attributable to late detection, chemotherapy resistance, and the absence of tailored therapies. Despite progress in surgical, radiation, and chemotherapy treatments, 80% of PDAC patients do not benefit optimally from systemic therapy, often due to asymptomatic presentation or disease regression upon diagnosis. The disease\u2019s progression is influenced by complex interactions involving immunological, genetic, and environmental factors, among others. However, the precise molecular mechanisms underlying PDAC remain incompletely understood. A major challenge in elucidating PDAC\u2019s origins lies in deciphering the genetic variations governing its network. PDAC exhibits heterogeneity, manifesting diverse genetic compositions, cellular attributes, and behaviors across patients and within tumors. This diversity complicates diagnosis, treatment strategies, and prognostication. Identification of \u201cDifferentially Expressed Genes\u201d (DEGs) between PDAC and healthy controls is vital for addressing these challenges. These DEGs serve as the foundation for constructing the PDAC protein interaction network, with their network properties being assessed for further insights. Our analysis revealed five key hub genes (KHGs): <jats:italic>EGF, SRC, SDC1, ICAM1 and CEACAM5<\/jats:italic>. The KHGs were predominantly enriched in pathways such as: ErbB signaling pathway, Rap1 signaling pathway, etc. Acknowledging the therapeutic promise and biomarker importance of PDAC KHGs, we have also pinpointed approved medications for the identified key genes. Nevertheless, it is crucial to conduct experimental validation on KHGs to confirm their effectiveness within the PDAC context. Overall, this study identified potential key hub genes implicated in the progression of PDAC, offering significant guidance for personalized clinical decision-making and molecular-targeted therapy for PDAC patients.<\/jats:p>","DOI":"10.3389\/fbinf.2025.1536783","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T06:19:35Z","timestamp":1743142775000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of key hub genes in pancreatic ductal adenocarcinoma: an integrative bioinformatics study"],"prefix":"10.3389","volume":"5","author":[{"given":"Kankana","family":"Bhattacharjee","sequence":"first","affiliation":[]},{"given":"Avik","family":"Sengupta","sequence":"additional","affiliation":[]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[]},{"given":"Aryya","family":"Ghosh","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"B2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1158\/1940-6207.capr-10-0025","article-title":"A migration signature and plasma biomarker panel for pancreatic adenocarcinoma","volume":"4","author":"Balasenthil","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0378-8733(98)00010-0","article-title":"Centrality measures for disease transmission networks","volume":"21","author":"Bell","year":"1999","journal-title":"Soc. Netw."},{"key":"B4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1742-481x.2009.00622.x","article-title":"Epidermal growth factor in clinical practice \u2013 a review of its biological actions, clinical indications and safety implications","volume":"6","author":"Berlanga-Acosta","year":"2009","journal-title":"Int. Wound J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.amjsurg.2008.04.009","article-title":"Molecular targeted therapies for pancreatic cancer","volume":"193","author":"Borja-Cacho","year":"2008","journal-title":"Am. J. Surg."},{"key":"B7","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Brad","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and Integrative Analysis of large gene lists using DAVID Bioinformatics resources","volume":"4","author":"Da","year":"2009","journal-title":"Nat. Protoc."},{"key":"B9","article-title":"A bioinformatics study for recognition of hub genes and pathways in pancreatic ductal adenocarcinoma","author":"Dafrazi","year":"2023","journal-title":"ArXiv"},{"key":"B10","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Damian","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1038\/s41416-023-02170-9","article-title":"Clinical and biological markers predictive of treatment response associated with metastatic pancreatic adenocarcinoma","volume":"128","author":"Dayimu","year":"2023","journal-title":"Br. J. Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1158\/1541-7786.mcr-19-0741","article-title":"Combined src\/EGFR inhibition targets STAT3 signaling and induces stromal remodeling to improve survival in pancreatic cancer","volume":"18","author":"Dosch","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"V56","DOI":"10.1093\/annonc\/mdv295","article-title":"Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Ducreux","year":"2015","journal-title":"Ann. Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1007\/s11538-018-0526-z","article-title":"Variability of betweenness centrality and its effect on identifying essential genes","volume":"81","author":"Duron","year":"2009","journal-title":"Bulletein Math. Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1124\/jpet.118.255786","article-title":"Combination therapies and drug delivery platforms in combating pancreatic cancer","volume":"370","author":"Fan","year":"2019","journal-title":"J. Pharmacol. Exp. Thr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13045-024-01561-6","article-title":"Current and future immunotherapeutic approaches in pancreatic cancer treatment","volume":"17","author":"Farhangnia","year":"2024","journal-title":"J. Hematol. and Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1634\/theoncologist.2012-0435","article-title":"FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts general hospital cancer center experience","volume":"18","author":"Faris","year":"2013","journal-title":"Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.semcdb.2014.01.011","article-title":"Epidermal growth factor, from gene organization to bedside","volume":"28","author":"Fenghua","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"affy\u2014analysis of Affymetrix GeneChip data at the probe level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ygeno.2017.01.005","article-title":"Improvements and impacts of GRCh38 human reference on high throughput sequencing data analysis","volume":"109","author":"Guo","year":"2017","journal-title":"Genomics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"53165","DOI":"10.18632\/oncotarget.10242","article-title":"Globally increased ultraconserved noncoding RNA expression in pancreatic adenocarcinoma","volume":"7","author":"Jiang","year":"2016","journal-title":"Oncotarget"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"Jones","year":"2008","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B25","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.ircmb.2014.10.001","article-title":"Epidermal growth factor signaling in transformed cells","volume":"314","author":"Lindsey","year":"2015","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.3892\/mmr.2019.10414","article-title":"Identification of differentially expressed genes in pancreatic ductal adenocarcinoma and normal pancreatic tissues based on microarray datasets","volume":"20","author":"Liu","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1007\/s11033-018-4325-2","article-title":"Identification of hub genes and analysis of prognostic values in pancreatic ductal adenocarcinoma by integrated bioinformatics methods","volume":"45","author":"Lu","year":"2018","journal-title":"Mol. Biol. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2129884","DOI":"10.1080\/08941939.2022.2129884","article-title":"Pancreatic cancer: a review of current treatment and novel therapies","volume":"36","author":"Mar Kolbeinsson","year":"2023","journal-title":"J. Investigative Surg."},{"key":"B31","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/biostatistics\/kxp059","article-title":"Frozen robust multiarray analysis (fRMA)","volume":"11","author":"McCall","year":"2010","journal-title":"Biostatistics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"5132","DOI":"10.1002\/cncr.27490","article-title":"Costs and trends in pancreatic cancer treatment","volume":"118","author":"O\u2019Neill","year":"2012","journal-title":"Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Paul","year":"2003","journal-title":"Genome Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1052672","DOI":"10.3389\/fonc.2022.1052672","article-title":"Roles of intercellular cell adhesion molecule-1 (ICAM-1) in colorectal cancer: expression, functions, prognosis, tumorigenesis, polymorphisms and therapeutic implications","volume":"12","author":"Qiu","year":"2022","journal-title":"Front. Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3390\/life11111187","article-title":"Target nanoparticles against pancreatic cancer: fewer side effects in therapy","volume":"11","author":"Roacho-P\u00e9rez","year":"2021","journal-title":"Life"},{"key":"B36","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2174\/1568026620666200303123102","article-title":"Review on epidermal growth factor receptor (EGFR) structure, signaling pathways, interactions, and recent updates of EGFR inhibitors","volume":"20","author":"Sabbah","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"key":"B178","first-page":"17","article-title":"Protein-protein interaction networks (PPI) and complex diseases","volume":"7","author":"Safari-Alighiarloo","year":"2014","journal-title":"Gastroenterol. Hepatol. Bed Bench."},{"key":"B37","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10585-007-9125-3","article-title":"Syndecan-1: a dynamic regulator of the myeloma microenvironment","volume":"25","author":"Sanderson","year":"2008","journal-title":"Clin. and Exp. Metastasis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"784983","DOI":"10.3389\/fcell.2021.784983","article-title":"The role and therapeutic value of syndecan-1 in cancer metastasis and drug resistance","volume":"9","author":"Sen","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fonc.2016.00099","article-title":"Targeting mTOR in pancreatic ductal adenocarcinoma","volume":"6","author":"Sentia","year":"2016","journal-title":"Front. Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"D1144","DOI":"10.1093\/nar\/gkaa1084","article-title":"Integration of the drug-gene interaction database (DGIdb 4.0) with open crowdsource efforts","volume":"49","author":"Sharon","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.12659\/msm.906313","article-title":"Possible molecular markers for the diagnosis of pancreatic ductal adenocarcinoma molecular markers for the diagnosis of pancreatic ductal adenocarcinoma","volume":"24","author":"Shen","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1186\/s12885-022-10397-7","article-title":"Identification of CEACAM5 as a stemness-related inhibitory immune-checkpoint in pancreatic cancer","volume":"22","author":"Shi","year":"2022","journal-title":"BMC Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/cancers14010217","article-title":"The impact of biomarkers in pancreatic ductal adenocarcinoma on diagnosis, surveillance and therapy","volume":"14","author":"Sturm","year":"2022","journal-title":"Cancers"},{"key":"B44","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ajpath.2018.10.005","article-title":"miRNA and gene expression in pancreatic ductal adenocarcinoma","volume":"189","author":"Tesfaye","year":"2019","journal-title":"Am. J. Pathol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/mog.0000000000000770","article-title":"Early detection of pancreatic cancer: current state and future opportunities","volume":"37","author":"Trikudanathan","year":"2021","journal-title":"Curr. Opin. Gastroenterol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/cancers9050052","article-title":"Epidermal growth factor receptor cell proliferation signaling pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers"},{"key":"B48","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1634\/theoncologist.2009-0009","article-title":"The role of SRC in solid tumors","volume":"14","author":"Wheeler","year":"2009","journal-title":"Oncologist"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.12688\/f1000research.15931.1","article-title":"FastQ ScreenA tool for multi-genome mapping and quality control","volume":"7","author":"Wingett","year":"2018","journal-title":"F1000Research"},{"key":"B50","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1186\/s12864-021-08137-5","article-title":"Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma","volume":"22","author":"Wu","year":"2021","journal-title":"BMC Genomics"},{"key":"B51","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1158\/2159-8290.cd-11-0031","article-title":"Pten is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-\u03baB-cytokine network","volume":"1","author":"Yinga","year":"2011","journal-title":"Cancer Discov."},{"key":"B52","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12957-018-1519-y","article-title":"Identification of hub genes with diagnostic values in pancreatic cancer by bioinformatics analyses and Supervised Learning methods","volume":"16","author":"Zhang","year":"2018","journal-title":"World J. Surg. Oncol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1147676","DOI":"10.3389\/fcell.2023.1147676","article-title":"KRAS mutation: the booster of pancreatic ductal adenocarcinoma transformation and progression","volume":"11","author":"Zhang","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1186\/s12885-018-4546-8","article-title":"Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes","volume":"18","author":"Zhao","year":"2018","journal-title":"BMC Canc"}],"container-title":["Frontiers in Bioinformatics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2025.1536783\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T06:19:47Z","timestamp":1743142787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2025.1536783\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":53,"alternative-id":["10.3389\/fbinf.2025.1536783"],"URL":"https:\/\/doi.org\/10.3389\/fbinf.2025.1536783","relation":{},"ISSN":["2673-7647"],"issn-type":[{"value":"2673-7647","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"article-number":"1536783"}}